Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair-Reference-Cited by-同舟云学术

Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair

Published:2022-12 Issue:3 Volume:10 Page:2205529
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Peng Xin¹²³⁴^ORCID,Zhang Shaolu¹²,Wang Yingying¹²,Zhou Zhicheng³⁴,Yu Zixiang¹²,Zhong Zhenxing¹²,Zhang Liang⁵,Chen Zhe‐Sheng⁶,Claret Francois X.³,Elkabets Moshe⁷,Wang Feng⁸,Sun Fan⁹,Wang Ran¹²,Liang Han³⁴,Lin Hou‐Wen⁹^ORCID,Kong Dexin¹²^ORCID

Affiliation:

1. Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics School of Pharmacy Tianjin Medical University Tianjin 300070 China

2. Key Laboratory of Immune Microenvironment and Diseases (Ministry of Education) Tianjin Medical University Tianjin 300070 China

3. Department of Bioinformatics and Computational Biology The University of Texas MD Anderson Cancer Center Houston TX 77030 USA

4. Department of Systems Biology the University of Texas MD Anderson Cancer Center Houston TX 77030 USA

5. Department of Pharmacology and Chemical Biology State Key Laboratory of Oncogenes and Related Genes Shanghai Jiao Tong University School of Medicine Shanghai 200025 China

6. Department of Pharmaceutical Sciences College of Pharmacy and Health Sciences St. John's University Queens NY 11439 USA

7. The Shraga Segal Department of Microbiology Immunology and Genetics Faculty of Health Sciences Ben‐Gurion University of the Negev Beer‐Sheva 84105 Israel

8. Department of Genetics School of Basic Medical Sciences Tianjin Medical University Tianjin 300070 China

9. Research Center for Marine Drugs State Key Laboratory of Oncogenes and Related Genes Department of Pharmacy Renji Hospital School of Medicine Shanghai Jiaotong University Shanghai 200127 China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202205529

Reference63 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

2. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion

3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

4. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

5. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of temozolomide and perifosine synergistically inhibit glioblastoma by impeding DNA repair and inducing apoptosis;Cell Death Discovery;2024-07-08

2. Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma;Advanced Science;2024-06-19

3. Prospects of marine-derived compounds as potential therapeutic agents for glioma;Pharmaceutical Biology;2024-06-12

4. Telomere-related DNA damage response pathways in cancer therapy: prospective targets;Frontiers in Pharmacology;2024-06-07

5. Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach;Chemico-Biological Interactions;2024-06